Multiple Sclerosis Trial, Recruiting (NCT02994121)

Multiple Sclerosis Trial, Recruiting NCT02994121 Sponsor: University of Pittsburgh Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT02994121 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with MS or a related condition:

People aged 7 years or older
People who are able to give their own consent (if aged 18 or over), or children under 18 who can give their agreement with permission from at least one parent or guardian
People who have been diagnosed with multiple sclerosis or a related condition, including those who have had a first episode of nervous system inflammation with MRI scan results consistent with MS, even if no symptoms have appeared yet

For healthy volunteers (people without MS):

People aged 7 years or older
People who are able to give their own consent (if aged 18 or over), or children under 18 who can give their agreement with permission from at least one parent or guardian
People with no personal history of multiple sclerosis or a related condition
People with no other ongoing long-term health conditions
Family members of someone with MS, people living in the same household, or members of the general public may be considered

Who may not be able to join:

There are no stated exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zongqi Xia, MD, PhD, University of Pittsburgh

Phone: 412-383-5377

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02994121

Sponsor: University of Pittsburgh

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 412-383-5377

More information: https://clinicaltrials.gov/study/NCT02994121

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with MS or a related condition:

People aged 7 years or older
People who are able to give their own consent (if aged 18 or over), or children under 18 who can give their agreement with permission from at least one parent or guardian
People who have been diagnosed with multiple sclerosis or a related condition, including those who have had a first episode of nervous system inflammation with MRI scan results consistent with MS, even if no symptoms have appeared yet

For healthy volunteers (people without MS):

People aged 7 years or older
People who are able to give their own consent (if aged 18 or over), or children under 18 who can give their agreement with permission from at least one parent or guardian
People with no personal history of multiple sclerosis or a related condition
People with no other ongoing long-term health conditions
Family members of someone with MS, people living in the same household, or members of the general public may be considered

Who may not be able to join:

There are no stated exclusion criteria for this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pittsburgh

Registry

ClinicalTrials.gov

Start date

1 December 2016

Est. completion

1 January 2047

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Establish a prospective cohort of well-characterized MS patients and controls; Investigate the predictors of the variations in disease trajectory and treatment response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov